Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: Role of pendrin and anion channels

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5144-5153

  Pedemonte, Nicoletta ^a,b   Caci, Emanuela ^a   Sondo, Elvira ^a   Caputo, Antonella ^a   Rhoden, Kerry ^c   Pfeffer, Ulrich ^d   Di Candia, Michele ^b   Bandettini, Roberto ^a   Ravazzolo, Roberto ^a   Zegarra Moran, Olga ^a   Galietta, Luis J V ^a,b,e  

^a G GASLINI INSTITUTE   (Italy)

^b Advanced Biotechnology Center   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e Laboratorio di Genetica Molecolare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANION CHANNEL; CALCIUM ACTIVATED CHLORIDE CHANNEL; CALCIUM ION; CHLORIDE CHANNEL; CYANIDE; CYCLIC AMP; HYDROGEN PEROXIDE; HYPOTHIOCYANITE; INTERLEUKIN 4; LACTOPEROXIDASE; PENDRIN; THIOCYANATE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BRONCHUS MUCOSA; CATALYSIS; CATALYST; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

EID: 34247165457     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5144     Document Type: Article

References (53)

1. Smith, J. J., and M. J. Welsh. 1993. Fluid and electrolyte transport by cultured human airway epithelia. J. Clin. Invest. 91: 1590-1597.
2. Boucher, R. C. 1994. Human airway ion transport: part two. Am. J. Respir. Crit. Care Med. 150: 581-593.
3. Coakley, R. D., B. R. Grubb, A. M. Paradiso, J. T. Gatzy, L. G. Johnson, S. M. Kreda, W. K. O'Neal, and R. C. Boucher. 2003. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc. Natl. Acad. Sci. USA 100: 16083-16088.
4. Matsui, H., B. R. Grubb, R. Tarran, S. H. Randell, J. T. Gatzy, C. W. Davis, and R. C. Boucher. 1998. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95: 1005-1015.
5. Boucher, R. C. 2004. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur. Respir. J. 23: 146-158.
6. + permeability in cystic fibrosis human primary cell cultures. J. Physiol. 405: 77-103.
7. Jentsch, T. J., V. Stein, F. Weinreich, and A. A. Zdebik. 2002. Molecular structure and physiological function of chloride channels. Physiol. Rev. 82: 503-568.
8. Sheppard, D. N., and M. J. Welsh. 1999. Structure and function of the CFTR chloride channel. Physiol. Rev. 79: S23-S45.
9. Galietta, L. J. V., P. Pagesy, C. Folli, E. Caci, L. Romio, B. Costes, E. Nicolis, G. Cabrini, M. Goossens, R. Ravazzolo, and O. Zegarra-Moran. 2002. 1L-4 is a potent modulator of ion transport in the human bronchial epithelium in vitro. J. Immunol. 168: 839-845.
10. Danahay, H., H. Atherton, G. Jones, R. J. Bridges, and C. T. Poll. 2002. Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. Am. J. Physiol. 282: L226-L236.
11. Fragoso, M. A., V. Fernandez, R. Forteza, R. H. Randell, M. Salathe, and G. E. Conner, 2004. Transcellular thiocyanate transport by human airway epithelia. J. Physiol. 561: 183-194.
12. Lundquist, P., B. Kagedal, and L. Nilsson. 1995. An improved method for determination of thiocyanate in plasma and urine. Eur. J. Clin. Chem. Clin. Biochem. 33: 343-349.
13. Schultz, C. P., M. K. Ahmed, C. Dawes, and H. H. Manisch. 1996. Thiocyanate levels in human saliva: quantitation by Fourier transform infrared spectroscopy. Anal. Biochem. 240: 7-12.
14. Tsuge, K., M. Kataoka, and Y. Seto. 2000. Cyanide and thiocyanate levels in blood and saliva of healthy adult volunteers. J. Health Sci. 46: 343-350.
15. Cowman, R. A., S. S. Baron, S. D. Obenauf, and J. J. Byrnes. 1983. Evidence for thiocyanate-sensitive peroxidase activity in human saliva. J. Clin. Microbiol. 18: 1177-1182.
16. Gaya, P., M. Medina, and M. Nunez. 1991. Effect of the lactoperoxidase system on Listeria monocytogenes behavior in raw milk at refrigeration temperatures. Appl. Environ. Microbiol. 57: 3355-3360.
17. Ihalin, R., V. Loimaranta, and J. Tenovuo. 2006. Origin, structure, and biological activities of peroxidases in human saliva. Arch. Biochem. Biophys. 445: 261-268.
18. Ratner, A. J., and A. Prince. 2000. Lactoperoxidase: new recognition of an "old" enzyme in airway defenses. Am. J. Respir. Cell Mol. Biol. 22: 642-644.
19. Gerson, C., J. Sabater, M. Scuri, A. Torbati, R. Coffey, J. W. Abraham, I. Lauredo, R. Forteza, A. Wanner, M. Salathe, et al. 2000. The lactoperoxidase system functions in bacterial clearance of airways. Am. J. Respir. Cell Mol. Biol. 22: 665-671.
20. Wijkstrom-Frei, C., S. El-Chemaly, R. Ali-Rachedi, C. Gerson, M. A. Cobas, R. Forteza, M. Salathe, and G. E. Conner. 2003. Lactoperoxidase and human airway host defense. Am. J. Respir. Cell Mol. Biol. 29: 206-212.
21. Forteza, R., M. Salathe, F. Miot, R. Forteza, and G. E. Conner. 2005. Regulated hydrogen peroxide production by Duox in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 32: 462-469.
22. 2-generating activity. J. Biol. Chem. 280: 30046-30054.
23. Schwarzer, C., T. E. Machen, B. Illek, and H. Fischer. 2004. NADPH oxidase-dependent acid production in airway epithelial cells. J. Biol. Chem. 279: 36454-36461.
24. Moskwa, P., D. Lorentzen, K. J. D. A. Excoffon, J. Zabner, P. B. McCray, W. M. Nauseef, C. Dupuy, and B. Banfi. 2007. A novel host defense system of airways is defective in cystic fibrosis. Am. J. Respir. Crit. Care Med. 175: 174-183.
25. Scott, D. A., R. Wang, T. M. Kreman, V. C. Sheffield, and L. P. Karniski. 1999. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat. Genet. 21: 440-443.
26. Galietta, L. J. V., L. Musante, L. Romio, U. Caruso, A. Fantasia, A. Gazzolo, L. Romano, O. Sacco, G. A. Rossi, L. Varesio, and O. Zegarra-Moran. 1998. An electrogenic amino acid transporter in the apical membrane of cultured human bronchial epithelial cells. Am. J. Physiol. 275: L917-L923.
27. Irizarry, R. A., B. M. Bolstad, F. Collin, L. M. Cope, B. Hobbs, and T. P. Speed. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31: e15.
28. Zhang, J., V. Carey, and R. Gentleman. 2003. An extensible application for assembling annotation for genomic data. Bioinformatics 19: 155-156.
29. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
30. Dennis, G. Jr., B. T. Sherman, D. A. Hosack, J. Yang, W. Gao, H. C. Lane, and R. A. Lempicki. 2002. DAVID; database for annotation, visualization, and integrated discovery. Genome Biol. 4: P3.
31. Skubis-Zegadlo, J., A. Nikodemska, E. Przytula, M. Mikula, K. Bardadin, J. Ostrowski, B. E. Wenzel, and B. Czarnocka. 2005. Expression of pendrin in benign and malignant human thyroid tissues. Br. J. Cancer 93: 144-151.
32. Taddei, A., C. Folli, O. Zegarra-Moran, P. Fanen, A. S. Verkman, and L. J. V. Galietta. 2004. Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett. 558: 52-56.
33. Caci, E., C. Folli, O. Zegarra-Moran, T. Ma, M. F. Springsteel, R. E. Sammelson, M. H. Nantz, M. J. Kurth, A. S. Verkman, and L. J. V. Galietta. 2003. CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds. Am. J. Physiol. 285: L180-L188.
34. Everett, L. A., H. Morsli, D. K. Wu, and E. D. Green. 1999. Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc. Natl. Acad. Sci. USA 96: 9727-9732.
35. Royaux, I. E., K. Suzuki, A. Mori, R. Katoh, L. A. Everett, L. D. Kohn, and E. D. Green. 2000. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141: 839-845.
36. Royaux, I. E., S. M. Wall, L. P. Karniski, L. A. Everett, K. Suzuki, M. A. Knepper, and E. D. Green. 2001. Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc. Natl. Acad. Sci. USA 98: 4221-4226.
37. - exchanger in the kidney cortex. Am. J. Physiol. 280: F356-F364.
38. Everett, L. A., B. Glaser, J. C. Beck, J. R. Idol, A. Buchs, M. Heyman, F. Adawi, E. Hazani, E. Nassir, A. D. Baxevanis, et al. 1997. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat. Genet. 17: 411-422.
39. Scott, D. A., R. Wang, T. M. Kreman, M. Andrews, J. M. McDonald, J. R. Bishop, R. J. Smith, L. P. Karniski, and V. C. Sheffield. 2000. Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum. Mol. Genet. 9: 1709-1715.
40. Jayaraman, S., P. Haggle, R. M. Wachter, S. J. Remington, and A. S. Verkman. 2000. Mechanism and cellular applications of a green fluorescent protein-based halide sensor. J. Biol. Chem. 275: 6047-6050.
41. Galietta, L. J. V., P. M. Haggle, and A. S. Verkman. 2001. Green fluorescent protein-based halide indicators with improved chloride and iodide affinities. FEBS Lett. 499: 220-224.
42. Linsdell, P., J. A. Tabcharani, and J. W. Hanrahan. 1997. Multi-Ion mechanism for ion permeation and block in the cystic fibrosis transmembrane conductance regulator chloride channel. J. Gen. Physiol. 110: 365-377.
43. Dossena, S., A. Maccagni, V. Vezzoii, C. Bazzini, M. L. Garavaglia, G. Meyer, J. Furst, M. Ritter, L. Fugazzola, L. Persani, et al. 2005. The expression of wild-type pendrin (SLC26A4) in human embryonic kidney (HEK 293 Phoenix) cells leads to the activation of cationic currents. Eur. J. Endocrinol. 153: 693-699.
44. Pedemonte, N., T. Diena, E. Caci, E. Nieddu, M. Mazzei, R. Ravazzolo, O. Zegarra-Moran, and L. J. V. Galietta. 2005. Antihypertensive 1,4-dihydropyridines as correctors of the cystic fibrosis transmembrane conductance regulator channel gating defect caused by cystic fibrosis mutations. Mol. Pharmacol. 68: 1736-1746.
45. Dossena, S., V. Vezzoii, N. Cerutti, C. Bazzini, M. Tosco, C. Sironi, S. Rodighiero, G. Meyer, U. Fascio, J. Furst, et al. 2006. Functional characterization of wild-type and a mutated form of SLC26A4 identified in a patient with Pendred syndrome. Cell. Physiol. Biochem. 17: 245-256.
46. Mason, S. J., A. M. Paradiso, and R. C. Boucher. 1991. Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br. J. Pharmacol. 103: 1649-1656.
47. Geiszt, M., I. Witta, I. Baffi, K. Lekstrom, and T. L. Leto. 2003. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17: 1502-1504.
48. Harper, R. W., C. Xu, J. P. Eiserich, Y. Chen, C. Y. Kao, P. Thai, H. Setiadi, and R. Wu. 2005. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett. 579: 4911-4917.
49. - conductances. J. Gen. Physiol. 120: 407-418.
50. Deterding, R., G. Retsch-Bogart, L. Milgram, R. Gibson, C. Daines, P. L. Zeitlin, C. Milla, B. Marshall, L. Lavange, J. Engels, et al. 2005. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatr. Pulmonol. 39: 339-348.
51. Thomas, E. L., and M. Fishman. 1986. Oxidation of chloride and thiocyanate by isolated leukocytes. J. Biol. Chem. 261: 9694-9702.
52. Slungaard, A., and J. R. Mahoney. 1991. Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids: implications for cytotoxicity. J. Biol. Chem. 266: 4903-4910.
53. van Dalen, C. J., and A. J. Kettle. 2001. Substrates and products of eosinophil peroxidase. Biochem. J. 358: 233-239.